PsychiatryCareLive

CME Speakers

Opioid Use Disorder

  • Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Associate Dean for Research and Professor of Medicine

    Peter D. Friedmann, MD, MPH, DFASAM, FACP, is a primary care internist, addiction medicine clinician, and established substance abuse researcher who has published over 145 peer-reviewed articles on the organization of treatment services, treatment process and outcomes, implementation of evidence-based practices for substance use disorders (SUDs) in medical, specialty addiction and correctional settings and the role of the physicians in the care of patients with SUDs. He is the chief research officer at Baystate Health, associate dean for research and professor of medicine at University of Massachusetts Medical School-Baystate, and professor of quantitative health sciences, University of Massachusetts Medical School. He received his medical degree from Boston University School of Medicine.
  • Genie L. Bailey, MD, DABAM

    Genie L. Bailey, MD, DABAM

    Genie L. Bailey, MD, DABAM

    Clinical Associate Professor of Psychiatry and Human Behavior

    Genie L. Bailey, MD, DABAM, is associate clinical professor of psychiatry and human behavior at Alpert Medical School, Brown University in Providence, Rhode Island, and is director of research and director of the Medication for Addiction Treatment (MAT) program at Stanley Street Treatment and Resources (SSTAR) in Fall River, Massachusetts. Dr Bailey was the site principal investigator (PI) for 3, multicenter randomized controlled trials funded through NIDA’s Clinical Trials Network, and a consortium PI on a project funded by NIH/NIDA to evaluate an implantable treatment for opioid dependency. She received her medical degree from Duke Medical School in Durham, North Carolina.
  • Joji Suzuki, MD

    Joji Suzuki, MD

    Joji Suzuki, MD

    Assistant Professor of Psychiatry

    Joji Suzuki, MD, is the director of the Division of Addiction Psychiatry and director of Addictions Education in the Department of Psychiatry, Brigham and Women’s Hospital, and an assistant professor of psychiatry at Harvard Medical School in Boston, Massachusetts. He is a consultation-liaison psychiatrist in the Division of Medical Psychiatry at Brigham and Women’s Hospital, and the site director for the Addiction Psychiatry Fellowships for Partners HealthCare and Boston University School of Medicine. Dr Suzuki’s research focuses on integrating evidence-based addiction treatment initiated in general medical setting. He has published over 50 peer-reviewed manuscripts and book chapters as first or co-author. Dr Suzuki received his medical degree from Boston University School of Medicine.

Schizophrenia

  • Abigail L. Donovan, MD

    Abigail L. Donovan, MD

    Abigail L. Donovan, MD

    Director, MGH First Episode and Early Psychosis Program

    Abigail Donovan, MD, is an associate psychiatrist at Massachusetts General Hospital (MGH) and assistant professor of psychiatry at Harvard Medical School in Boston. She is also the director of the First Episode and Early Psychosis Program and associate director of the Acute Psychiatry Service at MGH. Dr Donovan’s interests include the early diagnosis and treatment of schizophrenia in adolescents, as well as systems issues and quality of care improvement in acute psychiatry. She is the co-author of a book on child emergency psychiatry, and has been published in the Journal of the American Academy of Child and Adolescent Psychiatry, and the Journal of Clinical Psychiatry, amongst others. She earned her medical degree from the Yale University School of Medicine in New Haven, Connecticut.
  • Oliver Freudenreich, MD, FAPM

    Oliver Freudenreich, MD, FAPM

    Oliver Freudenreich, MD, FAPM

    Co-Director, MGH Schizophrenia Clinical and Research Program

    Oliver Freudenreich, MD, FAPM, is an associate professor of psychiatry at Harvard Medical School and a psychiatrist at Massachusetts General Hospital (MGH) in Boston. He is co-director of the MGH Schizophrenia Clinical and Research Program and directs the MGH Fellowship in Public and Community Psychiatry. His academic interests include optimal psychopharmacological treatment for schizophrenia, early course schizophrenia, the role of medical morbidity in schizophrenia, the integration of medicine and psychiatry, and treatment adherence. Dr Freudenreich serves a deputy editor for the journal, Psychosomatics, is published extensively in numerous journals, and has authored a handbook on psychotic disorders. He received his medical degree from the University of Heidelberg in Germany.

Major Depressive Disorder

  • Tonya L. Fancher, MD, MPH

    Tonya L. Fancher, MD, MPH

    Tonya L. Fancher, MD, MPH

    Professor, Department of Internal Medicine, Division of General Medicine

    Tonya L. Fancher, MD, MPH, is Associate Dean of Workforce Innovation and Interim Associate Dean for Diversity at the UC Davis School of Medicine. A primary care-trained general internist, her current research focuses on medical education, underserved care, the provision of mental health care in the primary care setting and depression in Southeast Asian populations. She is the director of the HRSA Center for a Diverse Health Care Workforce, and principal investigator on an American Medical Association grant for a 3-year accelerated pathway through medical school that is linked to primary care internal medicine and family medicine residency programs at UC Davis and Kaiser Permanente in Northern California. Dr Fancher received her medical degree from New York University School of Medicine.
  • Margaret L. Smith, MD, MPH, MHSA

    Margaret L. Smith, MD, MPH, MHSA

    Margaret L. Smith, MD, MPH, MHSA

    Assistant Professor, Department of Family Medicine

    Margaret L. Smith, MD, MPH, MHSA, is an assistant professor of family medicine at The University of Kansas Medical Center in Kansas City. Dr Smith has more than 20 years of clinical practice experience, and over 15 years of experience in medical student and resident education. She received her medical degree and Masters in Public Health from the Saint Louis University school of Medicine in Missouri. She completed a residency in family medicine and a Masters in Health Service Administration at the University of Kansas School of Medicine, as well as the Marshall University Affiliated Hospitals Combined Residency/Practice Program in Psychiatry in Huntington, West Virginia. Dr Smith also completed a primary care faculty development fellowship at Michigan State University in East Lansing.

Abuse-Deterrent Formulations

  • Jeffrey Gudin, MD

    Jeffrey Gudin, MD

    Jeffrey Gudin, MD

    Director, Pain Management and Palliative Care

    Jeffrey Gudin, MD, is the director of pain management and palliative care at Englewood Hospital and Medical Center in Englewood, New Jersey. His clinical and research focus includes pain management, opioid abuse and potential solutions, and increasing clinician awareness of pain assessment and risk management. A nationally recognized leader in pain management, Dr Gudin is active in teaching and research, and has collaborated with numerous initiatives to enhance responsible prescribing and the safe use of opioid pain medications. He serves as a consultant to state medical boards on challenging cases, as well as to industry on novel analgesic products and risk management associated with opioids. Dr. Gudin received his medical degree from Albany Medical College in Albany, New York.
  • Charles E. Argoff, MD

    Charles E. Argoff, MD

    Charles E. Argoff, MD

    Professor of Neurology

    Charles E. Argoff, MD, is professor of neurology at Albany Medical College, and director of the Comprehensive Pain Center at Albany Medical Center in Albany, New York. Dr Argoff specializes in pain management and chronic headaches, and has expertise in several types of pain treatments, including pharmacologic management, interventional pain management and the use of botulinum toxins. He is currently president of the American Academy of Pain Medicine Foundation, the neuropathic pain section co-editor for Pain Medicine, serves on the editorial boards of Applied Neurology, BMC Neurology and Clinical Journal of Pain, and is co-author of Defeat Chronic Pain Now, a book for people with chronic pain. He received his medical degree from Northwestern University Medical School in Chicago, Illinois.

Alzheimer's Disease

  • Stephen P. Salloway, MD, MS

    Stephen P. Salloway, MD, MS

    Stephen P. Salloway, MD, MS

    Professor of Neurology and Psychiatry

    Stephen Salloway, MD, MS, is chief of neurology and director of the Memory and Aging Program at Butler Hospital, and professor of neurology and psychiatry at the Alpert Medical School of Brown University in Providence, Rhode Island. Under his direction, the Butler Hospital Memory and Aging Program has conducted more than 75 clinical trials developing new diagnostic tests and treatments for memory loss, and his program is currently conducting 5 prevention trials for individuals at high risk for Alzheimer’s disease (AD). Dr Salloway has published over 300 scientific articles and abstracts, edited 3 books, and lectures widely about early diagnosis and treatment of AD. He received his MD from Stanford Medical School, and completed residencies in neurology and psychiatry at Yale University.

All Speakers

  • Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Associate Dean for Research and Professor of Medicine

    Peter D. Friedmann, MD, MPH, DFASAM, FACP, is a primary care internist, addiction medicine clinician, and established substance abuse researcher who has published over 145 peer-reviewed articles on the organization of treatment services, treatment process and outcomes, implementation of evidence-based practices for substance use disorders (SUDs) in medical, specialty addiction and correctional settings and the role of the physicians in the care of patients with SUDs. He is the chief research officer at Baystate Health, associate dean for research and professor of medicine at University of Massachusetts Medical School-Baystate, and professor of quantitative health sciences, University of Massachusetts Medical School. He received his medical degree from Boston University School of Medicine.
  • Genie L. Bailey, MD, DABAM

    Genie L. Bailey, MD, DABAM

    Genie L. Bailey, MD, DABAM

    Clinical Associate Professor of Psychiatry and Human Behavior

    Genie L. Bailey, MD, DABAM, is associate clinical professor of psychiatry and human behavior at Alpert Medical School, Brown University in Providence, Rhode Island, and is director of research and director of the Medication for Addiction Treatment (MAT) program at Stanley Street Treatment and Resources (SSTAR) in Fall River, Massachusetts. Dr Bailey was the site principal investigator (PI) for 3, multicenter randomized controlled trials funded through NIDA’s Clinical Trials Network, and a consortium PI on a project funded by NIH/NIDA to evaluate an implantable treatment for opioid dependency. She received her medical degree from Duke Medical School in Durham, North Carolina.
  • Joji Suzuki, MD

    Joji Suzuki, MD

    Joji Suzuki, MD

    Assistant Professor of Psychiatry

    Joji Suzuki, MD, is the director of the Division of Addiction Psychiatry and director of Addictions Education in the Department of Psychiatry, Brigham and Women’s Hospital, and an assistant professor of psychiatry at Harvard Medical School in Boston, Massachusetts. He is a consultation-liaison psychiatrist in the Division of Medical Psychiatry at Brigham and Women’s Hospital, and the site director for the Addiction Psychiatry Fellowships for Partners HealthCare and Boston University School of Medicine. Dr Suzuki’s research focuses on integrating evidence-based addiction treatment initiated in general medical setting. He has published over 50 peer-reviewed manuscripts and book chapters as first or co-author. Dr Suzuki received his medical degree from Boston University School of Medicine.
  • Abigail L. Donovan, MD

    Abigail L. Donovan, MD

    Abigail L. Donovan, MD

    Director, MGH First Episode and Early Psychosis Program

    Abigail Donovan, MD, is an associate psychiatrist at Massachusetts General Hospital (MGH) and assistant professor of psychiatry at Harvard Medical School in Boston. She is also the director of the First Episode and Early Psychosis Program and associate director of the Acute Psychiatry Service at MGH. Dr Donovan’s interests include the early diagnosis and treatment of schizophrenia in adolescents, as well as systems issues and quality of care improvement in acute psychiatry. She is the co-author of a book on child emergency psychiatry, and has been published in the Journal of the American Academy of Child and Adolescent Psychiatry, and the Journal of Clinical Psychiatry, amongst others. She earned her medical degree from the Yale University School of Medicine in New Haven, Connecticut.
  • Oliver Freudenreich, MD, FAPM

    Oliver Freudenreich, MD, FAPM

    Oliver Freudenreich, MD, FAPM

    Co-Director, MGH Schizophrenia Clinical and Research Program

    Oliver Freudenreich, MD, FAPM, is an associate professor of psychiatry at Harvard Medical School and a psychiatrist at Massachusetts General Hospital (MGH) in Boston. He is co-director of the MGH Schizophrenia Clinical and Research Program and directs the MGH Fellowship in Public and Community Psychiatry. His academic interests include optimal psychopharmacological treatment for schizophrenia, early course schizophrenia, the role of medical morbidity in schizophrenia, the integration of medicine and psychiatry, and treatment adherence. Dr Freudenreich serves a deputy editor for the journal, Psychosomatics, is published extensively in numerous journals, and has authored a handbook on psychotic disorders. He received his medical degree from the University of Heidelberg in Germany.
  • Tonya L. Fancher, MD, MPH

    Tonya L. Fancher, MD, MPH

    Tonya L. Fancher, MD, MPH

    Professor, Department of Internal Medicine, Division of General Medicine

    Tonya L. Fancher, MD, MPH, is Associate Dean of Workforce Innovation and Interim Associate Dean for Diversity at the UC Davis School of Medicine. A primary care-trained general internist, her current research focuses on medical education, underserved care, the provision of mental health care in the primary care setting and depression in Southeast Asian populations. She is the director of the HRSA Center for a Diverse Health Care Workforce, and principal investigator on an American Medical Association grant for a 3-year accelerated pathway through medical school that is linked to primary care internal medicine and family medicine residency programs at UC Davis and Kaiser Permanente in Northern California. Dr Fancher received her medical degree from New York University School of Medicine.
  • Margaret L. Smith, MD, MPH, MHSA

    Margaret L. Smith, MD, MPH, MHSA

    Margaret L. Smith, MD, MPH, MHSA

    Assistant Professor, Department of Family Medicine

    Margaret L. Smith, MD, MPH, MHSA, is an assistant professor of family medicine at The University of Kansas Medical Center in Kansas City. Dr Smith has more than 20 years of clinical practice experience, and over 15 years of experience in medical student and resident education. She received her medical degree and Masters in Public Health from the Saint Louis University school of Medicine in Missouri. She completed a residency in family medicine and a Masters in Health Service Administration at the University of Kansas School of Medicine, as well as the Marshall University Affiliated Hospitals Combined Residency/Practice Program in Psychiatry in Huntington, West Virginia. Dr Smith also completed a primary care faculty development fellowship at Michigan State University in East Lansing.
  • Jeffrey Gudin, MD

    Jeffrey Gudin, MD

    Jeffrey Gudin, MD

    Director, Pain Management and Palliative Care

    Jeffrey Gudin, MD, is the director of pain management and palliative care at Englewood Hospital and Medical Center in Englewood, New Jersey. His clinical and research focus includes pain management, opioid abuse and potential solutions, and increasing clinician awareness of pain assessment and risk management. A nationally recognized leader in pain management, Dr Gudin is active in teaching and research, and has collaborated with numerous initiatives to enhance responsible prescribing and the safe use of opioid pain medications. He serves as a consultant to state medical boards on challenging cases, as well as to industry on novel analgesic products and risk management associated with opioids. Dr. Gudin received his medical degree from Albany Medical College in Albany, New York.
  • Charles E. Argoff, MD

    Charles E. Argoff, MD

    Charles E. Argoff, MD

    Professor of Neurology

    Charles E. Argoff, MD, is professor of neurology at Albany Medical College, and director of the Comprehensive Pain Center at Albany Medical Center in Albany, New York. Dr Argoff specializes in pain management and chronic headaches, and has expertise in several types of pain treatments, including pharmacologic management, interventional pain management and the use of botulinum toxins. He is currently president of the American Academy of Pain Medicine Foundation, the neuropathic pain section co-editor for Pain Medicine, serves on the editorial boards of Applied Neurology, BMC Neurology and Clinical Journal of Pain, and is co-author of Defeat Chronic Pain Now, a book for people with chronic pain. He received his medical degree from Northwestern University Medical School in Chicago, Illinois.
  • Stephen P. Salloway, MD, MS

    Stephen P. Salloway, MD, MS

    Stephen P. Salloway, MD, MS

    Professor of Neurology and Psychiatry

    Stephen Salloway, MD, MS, is chief of neurology and director of the Memory and Aging Program at Butler Hospital, and professor of neurology and psychiatry at the Alpert Medical School of Brown University in Providence, Rhode Island. Under his direction, the Butler Hospital Memory and Aging Program has conducted more than 75 clinical trials developing new diagnostic tests and treatments for memory loss, and his program is currently conducting 5 prevention trials for individuals at high risk for Alzheimer’s disease (AD). Dr Salloway has published over 300 scientific articles and abstracts, edited 3 books, and lectures widely about early diagnosis and treatment of AD. He received his MD from Stanford Medical School, and completed residencies in neurology and psychiatry at Yale University.